Have a personal or library account? Click to login
Ocular changes in metastatic melanoma patients treated with MEK inhibitor cobimetinib and BRAF inhibitor vemurafenib Cover

Ocular changes in metastatic melanoma patients treated with MEK inhibitor cobimetinib and BRAF inhibitor vemurafenib

Radiology and Oncology
Volume 52 (2018): Issue 2 (June 2018)
By:
Open Access
|Jan 2018
DOI: https://doi.org/10.2478/raon-2018-0002 | Journal eISSN: 1581-3207 | Journal ISSN: 1318-2099
Journal RSS Feed
Language: English
Page range: 213 - 219
Submitted on: Oct 4, 2017
Accepted on: Nov 20, 2017
Published on: Jan 24, 2018
Published by: Association of Radiology and Oncology
In partnership with: Paradigm Publishing Services
Publication frequency: 4 times per year
Keywords:
metastatic malignant melanoma,
eye,
MEKAR,
MEK inhibitor
Related subjects:
Medicine,
Clinical medicine,
Internal medicine,
Haematology, oncology,
Radiology

© 2018 Ana Ursula Gavric, Janja Ocvirk, Polona Jaki Mekjavic, published by Association of Radiology and Oncology
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.

Previous articleVolume 52 (2018): Issue 2 (June 2018)Next article